Unity Biotechnology CEO Anirvan Ghosh receives $7.4M in 2020

Unity Biotechnology reports 2020 executive compensation

By ExecPay News

Published: April 30, 2021

Unity Biotechnology reported fiscal year 2020 executive compensation information on April 30, 2021.
In 2020, four executives at Unity Biotechnology received on average a compensation package of $3.2M, a 57% increase compared to previous year.
Average pay of disclosed executives at Unity Biotechnology
Anirvan Ghosh, Chief Executive Officer, received $7.4M in total. 56% of Ghosh's compensation, or $4.2M, was in option awards. Ghosh also received $75K in bonus, $213K in non-equity incentive plan, $417K in salary, $2.5M in stock awards, as well as $54K in other compensation.
Lynne Sullivan, Chief Financial Officer, received a compensation package of $2.9M. 67% of the compensation package, or $1.9M, was in option awards.
Jamie Dananberg, Chief Medical Officer, earned $1.9M in 2020, a 20% increase compared to previous year.
Keith R. Leonard Jr, Chief Executive Officer, received $576K in 2020, which decreases by 82% compared to 2019.

Related executives

Anirvan Ghosh

Unity Biotechnology

Chief Executive Officer

Keith Leonard

Unity Biotechnology

Chief Executive Officer

Lynne Sullivan

Unity Biotechnology

Chief Financial Officer

Jamie Dananberg

Unity Biotechnology

Chief Medical Officer

You may also like

Source: SEC filing on April 30, 2021.